91˿Ƶ

91˿Ƶ researchers contribute to international study on DNA synthesis

A study published in Science reveals how a single protein helps cells decide when to produce the building blocks of DNA — a discovery with potential implications for treatments of cancer and inherited metabolic disorders

Inside every cell, a finely tuned metabolic network determines when to build, recycle, or stop producing essential molecules. A central part of this network is folate metabolism, which provides vital chemical units for the synthesis of DNA, RNA and amino acids. When this system is disturbed – through genetic mutations or a lack of dietary folates – the consequences can range from developmental disorders to cancer.

Now, researchers from , the Research Center for Molecular Medicine of the Austrian Academy of Sciences, together with collaborators from the University of Oxford and contributors from The Research Institute of the 91˿Ƶ Health Centre (The Institute), have identified an unexpected player in this metabolic balance: the enzyme NUDT5.

The study, published in , shows that NUDT5 helps switch off purine production—the pathway that generates the building blocks of DNA—but does so without using its enzymatic activity. Instead, the protein acts as a kind of molecular scaffold that physically restrains a key biosynthetic step when purine levels are already high.

“We were delighted to play a role in this important work, by providing cultured cells from patients with mutations in the MTHFD1 gene,” said , one of the study’s co-authors and a Scientist in the  at The Institute. “Cells from patients with a genetic disease, which we , were critical in showing that adenosine can also be toxic depending on the exact nature of the MTHFD1ܳٲپDz.”

Back to top